戒烟的新兴和既定的药物疗法:一项审查
Ellen N Huhulea1, William H Frishman1, Wilbert S Aronow2
1From the Department of Medicine, New York Medical College, Valhalla, NY.
Cardiology in review
|February 16, 2026
概括
戒烟疗法正在得到改善,瓦雷尼克林和组合尼古丁替代疗法显示出高效. 新兴的选择,如细胞素和GLP-1激动剂提供潜在的好处,但需要进一步的研究,以获得最佳的戒烟成功.
科学领域:
- 药理学和公共卫生
- 成 药物 药物 药物 药物
- 预防心血管疾病 预防心血管疾病
背景情况:
- 烟草使用是美国首要可预防的死亡原因,与显著的心血管疾病和死亡率有关.
- 尽管有可用的治疗方法,但许多人仍然很难实现持续的戒烟.
- 有效的戒烟策略对于公共健康和减少医疗保健负担至关重要.
研究的目的:
- 审查用于戒烟的既定和新药疗法.
- 评估最近关于细胞素和葡萄糖类-1 (GLP-1) 受体激活剂的证据.
- 讨论行为干预在提高戒烟成果中的作用.
主要方法:
- 关于戒烟药物治疗的现有文献的叙事综述.
- 专注于瓦雷尼克林,尼古丁替代疗法,细胞素和GLP-1受体激动剂的证据.
- 包括有关行为干预措施的数据,如咨询和应急管理.
主要成果:
- 瓦伦尼克林和组合尼古丁替代疗法是高效的第一线药物.
- 赛提辛作为一种耐受性良好且具有成本效益的替代品显示出前景.
- GLP-1受体激动剂可能有助于管理停止后的体重增加,并支持特定人群的禁欲.
- 行为干预在组合时显著提高药理治疗疗效.
结论:
- 目前的戒烟疗法提高了戒烟率,但实现完全戒烟是具有挑战性的.
- 对于组合疗法,精准医学以及新疗法的长期安全性,进一步的研究是必不可少的.
- 优化戒烟需要一个多方面的方法,整合药物治疗和行为支持.
更多相关视频
06:39Electroencephalographic, Heart Rate, and Galvanic Skin Response Assessment for an Advertising Perception Study: Application to Antismoking Public Service Announcements
Published on: August 28, 2017
15.0K
08:47Spectral Confocal Imaging of Fluorescently tagged Nicotinic Receptors in Knock-in Mice with Chronic Nicotine Administration
Published on: February 10, 2012
14.0K
相关概念视频
01:29Stimulants
1.0K
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
1.0K
01:27CNS Depressants: Alcohol and Nicotine
1.3K
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
1.3K
01:23Drugs Acting on Autonomic Ganglia: Stimulants
2.1K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
2.1K
01:17Drug Dependence
1.8K
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
1.8K
01:23Antidepressant Drugs: MAOIs and Other Agents
964
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
964
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.3K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.3K